ESS accelerator cryogenic plant

Wang, Xilong; Weisend, J. G.; Koettig, T.; Hees, Wolfgang; Darve, Christine

doi:10.1080/10789669.2014.888369

Cited by 7 publications

(1 citation statement)

References 6 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…While these safety factors may change as the ESS design develops, expressing them explicitly allows for discussion and avoids hidden margin in the design. The Accelerator Cryoplant is further described in Reference [4].…”

Section: Accelerator Cryoplantmentioning

confidence: 99%

Status of the ESS cryogenic system

Weisend

Darve

Gallimore

et al. 2014

AIP Conference Proceedings

View full text Add to dashboard Cite

Abstract. The European Spallation Source (ESS) is a neutron science facility funded by a collaboration of 17 European countries currently under design and construction in Lund, Sweden. The centerpiece of ESS is a 2.5 GeV proton linac utilizing superconducting RF cavities operating at 2 K. In addition to cooling the SRF cavities, cryogenics is also used at ESS in the liquid hydrogen moderators surrounding the target. ESS also uses both liquid helium and liquid nitrogen in a number of the planned neutron instruments. There is also a significant cryogenic installation associated with the site acceptance testing of the ESS cryomodules. The ESS cryogenic system consists of 3 separate helium refrigeration/liquefaction plants supplying the accelerator, target moderators and instruments. An extensive cryogenic distribution system connects the accelerator cryoplant with the cryomodules. This paper describes the preliminary design of the ESS cryogenic system including the expected heat loads. Challenges associated with the required high reliability and turn-down capability will also be discussed. A unique feature of ESS is its commitment to sustainability and energy recovery. A conceptual design for recovering waste heat from the helium compressors for use in the Lund district heating system will also be described.

show abstract

Section: Accelerator Cryoplantmentioning

confidence: 99%